ArticlePloS one2024

Effects of aflibercept and bevacizumab on cell viability, cell metabolism and inflammation in hypoxic human Müller cells.

Monique Matsuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.